Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Notes on the pathogenesis of multiple sclerosis

C M Poser1

  • 1Harvard Neurological Unit, Beth Israel Hospital, Boston, MA 02215, USA.

Clinical Neuroscience (New York, N.Y.)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise and Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.

The Physician and sportsmedicine·2016
Same author

Disseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical review.

Acta neurologica Scandinavica·2007
Same author

The diagnosis and management of multiple sclerosis.

Acta neurologica Scandinavica·2005
Same author

Multiple sclerosis trait: the premorbid stage of multiple sclerosis. A hypothesis.

Acta neurologica Scandinavica·2004
Same author

Optic neuromyelitis syndrome in Brazilian patients.

Journal of neurology, neurosurgery, and psychiatry·2002
Same author

Problems with diagnostic criteria for multiple sclerosis.

Lancet (London, England)·2001
Same journal

Cardiovascular autonomic dysfunction in parkinsonian patients.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Visuo-cognitive dysfunctions in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Gastrointestinal dysfunction in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Respiratory function in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Neurophysiology of sensorimotor integration in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Imaging of nonmotor symptoms in Parkinson syndromes.

Clinical neuroscience (New York, N.Y.)·2000
See all related articles

Multiple sclerosis (MS) risk involves genetic susceptibility and environmental factors. An initial antigenic challenge can trigger an asymptomatic immune response and increase blood-brain barrier (BBB) vulnerability, potentially leading to MS.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Environmental Health

Background:

  • Multiple sclerosis (MS) pathogenesis is multifactorial, influenced by genetic predisposition and environmental triggers.
  • An initial immune system activation and blood-brain barrier (BBB) vulnerability characterize an early, asymptomatic stage of MS.
  • Subsequent antigenic challenges or trauma can compromise the BBB, initiating the inflammatory cascade.

Purpose of the Study:

  • To elucidate the sequential events in multiple sclerosis development.
  • To identify critical factors and stages in MS pathogenesis.
  • To understand the role of the blood-brain barrier (BBB) in MS initiation and progression.

Main Methods:

  • Review of existing literature on MS etiology and pathogenesis.

Related Experiment Videos

  • Analysis of the proposed mechanisms involving genetic susceptibility, antigenic challenges, and BBB alterations.
  • Examination of the molecular mimicry phenomenon in immune responses.

    • Main Results:

    • Genetic susceptibility combined with environmental factors, such as viral challenges, initiates MS.
    • The initial stage involves an activated immune system and increased BBB permeability, which may remain asymptomatic.
    • A second antigenic challenge or trauma leads to BBB alteration via molecular mimicry, allowing immune cell infiltration and myelin sheath inflammation, forming the initial MS lesion.

    Conclusions:

    • MS development is a staged process initiated by genetic and environmental interactions.
    • BBB alteration is a crucial, albeit not fully understood, step in MS pathogenesis.
    • The initial inflammatory stage is reversible, but subsequent myelin breakdown can lead to a progressive, self-perpetuating disease.